With the continued use of COVID-19 vaccines worldwide, there’s a massive amount of data that shows mRNA shots are safe.
In the past week, Moderna reported third-quarter 2025 earnings with revenue at US$1.02 billion, down sharply from the ...
CAMBRIDGE, MA / ACCESS Newswire / October 22, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced topline results from a Phase 3 pivotal trial evaluating the efficacy of mRNA-1647, the Company’s ...
StockStory.org on MSN
Why Moderna (MRNA) Stock Is Falling Today
Shares of biotechnology company Moderna (NASDAQ:MRNA) fell 6.9% in the afternoon session after ongoing concerns about its ...
WASHINGTON -- Moderna is applying for full government approval for its COVID-19 vaccine. The company said it is submitting trial data to the Food and Drug Administration on a rolling basis over the ...
11don MSN
Moderna Q3 preview: What to expect
Get the latest on Moderna’s Q3 earnings, analyst forecasts, COVID-19 vaccine sales impact, and what could shape MRNA’s stock ...
StockStory.org on MSN
Gilead Sciences, Moderna, Artivion, Tenet Healthcare, and Charles River Laboratories Stocks Trade Up, What You Need To Know
What Happened? A number of stocks jumped in the afternoon session after the market experienced a sharp sector rotation, as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback